{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Colesevelam+placebo", "query": { "intervention": "Colesevelam placebo" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 29, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Colesevelam+placebo&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-12T13:51:09.999Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00147719", "title": "WelChol® With Metformin in Treating Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Colesevelam hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 300, "start_date": "2004-06", "completion_date": "2006-07", "has_results": false, "last_update_posted_date": "2012-01-18", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 46, "location_summary": "Jonesboro, Arkansas • Beverly Hills, California • Carmichael, California + 43 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Carmichael", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00147719" }, { "nct_id": "NCT00570739", "title": "Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus", "Hypercholesterolemia", "Pre-diabetes" ], "interventions": [ { "name": "Metformin HCl and Colesevelam Placebo", "type": "DRUG" }, { "name": "Metformin HCl tablets and Colesevelam tablets", "type": "DRUG" }, { "name": "Colesevelam placebo", "type": "DRUG" }, { "name": "Colesevelam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 502, "start_date": "2007-11", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2010-07-27", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Los Gatos, California • Tarzana, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Gatos", "state": "California" }, { "city": "Tarzana", "state": "California" }, { "city": "Ocala", "state": "Florida" }, { "city": "Pocatello", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT00570739" }, { "nct_id": "NCT00938405", "title": "Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 1", "Hyperlipidemias" ], "interventions": [ { "name": "Colesevelam HCl", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 45, "start_date": "2009-07", "completion_date": "2009-12", "has_results": false, "last_update_posted_date": "2014-05-20", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00938405" }, { "nct_id": "NCT00361153", "title": "Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Colesevelam hydrochloride", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 35, "start_date": "2006-05", "completion_date": "2007-03", "has_results": false, "last_update_posted_date": "2008-06-25", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00361153" }, { "nct_id": "NCT00951899", "title": "The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Diet", "type": "BEHAVIORAL" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER", "BEHAVIORAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "35 Years to 70 Years" }, "enrollment_count": 38, "start_date": "2009-08", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2013-11-11", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00951899" }, { "nct_id": "NCT01239004", "title": "Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dyslipidemia", "Hyperlipidemia", "Hyperglycemia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Colesevelam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Radiant Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2010-11", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2012-01-06", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 4, "location_summary": "Chicago, Illinois • Kansas City, Kansas • Minneapolis, Minnesota + 1 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01239004" }, { "nct_id": "NCT01258075", "title": "Colesevelam for Children With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "High-dose colesevelam", "type": "DRUG" }, { "name": "Low-dose colesevelam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 236, "start_date": "2011-02-24", "completion_date": "2020-04-21", "has_results": true, "last_update_posted_date": "2021-05-13", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 24, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 20 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01258075" }, { "nct_id": "NCT00185107", "title": "Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Colesevelam Hydrochloride", "type": "DRUG" }, { "name": "Ezetimibe", "type": "DRUG" }, { "name": "Simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 45, "start_date": "2005-03", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2007-09-11", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 7, "location_summary": "San Diego, California • Ocala, Florida • Overland Park, Kansas + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Ocala", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Edina", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00185107" }, { "nct_id": "NCT00789750", "title": "Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 562, "start_date": "2009-04", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2017-06-26", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 141, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Green Valley, Arizona + 114 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00789750" }, { "nct_id": "NCT00596427", "title": "Mechanisms of Glucose Lowering Effect of Colesevelam HCl", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "Colesevelam HCL", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Carine Beysen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "30 Years to 70 Years" }, "enrollment_count": 60, "start_date": "2007-11", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2012-10-12", "last_synced_at": "2026-09-12T13:51:09.999Z", "location_count": 3, "location_summary": "Walnut Creek, California • Miami, Florida • San Antonio, Texas", "locations": [ { "city": "Walnut Creek", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00596427" } ] }